Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.2%
0%
1.2%
6 Months
1.2%
0%
1.2%
1 Year
26.5%
0%
26.5%
2 Years
63.23%
0%
63.23%
3 Years
83.33%
0%
83.33%
4 Years
57.14%
0%
57.14%
5 Years
0%
0%
0.0%
Hatinh Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.70%
EBIT Growth (5y)
6.79%
EBIT to Interest (avg)
4.21
Debt to EBITDA (avg)
1.34
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
2.42
Tax Ratio
20.48%
Dividend Payout Ratio
91.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.26%
ROE (avg)
9.10%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
2.33
EV to EBITDA
1.47
EV to Capital Employed
0.28
EV to Sales
0.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.78%
ROE (Latest)
9.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
473,580.80
346,665.30
36.61%
Operating Profit (PBDIT) excl Other Income
37,236.90
30,071.10
23.83%
Interest
4,190.10
4,033.20
3.89%
Exceptional Items
164.80
0.00
Consolidate Net Profit
16,849.50
9,523.50
76.93%
Operating Profit Margin (Excl OI)
54.60%
46.70%
0.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 36.61% vs 5.06% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is 76.93% vs 31.17% in Dec 2021
About Hatinh Pharmaceutical JSC 
Hatinh Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Hatinh Pharmaceutical Joint Stock Company (Hadiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities include the manufacture and distribution of diversified medicinal products, such as antibiotics, pain killers, anti-inflammatory and anti-allergy drugs, topical cream, nervine tonics, vitamins, Chinese medicine and functional food, among others. Hadiphar is also involved in the production of medicinal materials and the wholesale of pharmaceuticals.
Company Coordinates 
Company Details
So 167 duong Ha Huy Tap, phuong Nam Ha , HA TINH None : None
Registrar Details






